Convatec Group PLC (LON:CTEC)
248.60
0.00 (0.00%)
Nov 10, 2026, 4:49 PM GMT
Convatec Group Market Cap
Convatec Group has a market cap or net worth of 4.86 billion as of November 10, 2026. It is the 2,960th most valuable company in the world and the 81st biggest in the United Kingdom. Its market cap has increased by 4.42% in one year.
Market Cap
4.86B
Enterprise Value
6.10B
Revenue
1.88B
Global Rank
Country Rank
#81 United Kingdom
PE Ratio
53.23
ChartMarket Cap Chart
Since October 26, 2016, Convatec Group's market cap has increased from 4.39B to 4.86B, an increase of 10.66%. That is a compound annual growth rate of 1.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 4.86B | 2.49% |
| Dec 31, 2025 | 4.74B | 4.77% |
| Dec 31, 2024 | 4.53B | -9.11% |
| Dec 29, 2023 | 4.98B | 4.77% |
| Dec 30, 2022 | 4.75B | 22.28% |
| Dec 31, 2021 | 3.89B | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.02B |
| GSK plc | 77.23B |
| Haleon | 29.08B |
| Smith & Nephew | 9.60B |
| Hikma Pharmaceuticals | 3.36B |
| Oxford Nanopore Technologies | 2.04B |
| HUTCHMED (China) | 1.98B |
| Genus | 1.56B |